Koneczny M, Erol AB, Mauduit M, Eisen MS, Tamm M. Titanium complexes with unsymmetrically substituted imidazolin-2-iminato ligands.
Dalton Trans 2022;
51:11448-11456. [PMID:
35822511 DOI:
10.1039/d2dt01740g]
[Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The reaction of the unsymmetrical N-heterocyclic carbenes 1-(2,4,6-trimethylphenyl)-3-(adamantyl)imidazolin-2-ylidene (IAdMes, 1a) and 1-(2,6-diisopropylphenyl)-3-(adamantyl)imidazolin-2-ylidene (IAdDipp, 1b) with trimethylsilyl azide furnished the 2-(trimethylsilylimino)imidazolines 2a (ImAdMesNSiMe3) and 2b (ImAdDippNSiMe3). Desilylation by stirring in methanol gave the corresponding imidazolin-2-imines 3a (ImAdMesNH) and 3b (ImAdDippNH). 2a and 2b were treated with [TiCl4(THF)2] (THF = tetrahydrofuran) and [CpTiCl3] (Cp = η5-C5H5) to form the mono- and bis(imidazolin-2-iminato) titanium(IV) complexes [(ImAdRN)TiCl3] (4, R = Mes, Dipp), [Cp(ImAdRN)TiCl2] (5, R = Mes, Dipp), and [(ImAdRN)2TiCl2] (6, R = Mes, Dipp). The crystal structures of all compounds except 2b were determined by X-ray diffraction analysis.
Collapse